Re-evaluation of various molecular targets located on CD34+CD38-Lin- leukemia stem cells and other cell subsets in pediatric acute myeloid leukemia

Author：            

Publisher： Spandidos Publications

E-ISSN： 1792-1082|11|1|891-897

ISSN： 1792-1074

Source： Oncology Letters, Vol.11, Iss.1, 2016-01, pp. : 891-897

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Acute Myeloid Leukemia Stem Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 2, 2010-01 ,pp. : 104-110

Bentham Science Publishers

Access to resources Recommend Favorite

In vitro effects of imatinib on CD34+ cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase

By              

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 791-796

Spandidos Publications

Access to resources Recommend Favorite

CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia

By                  

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 825-830

Spandidos Publications

Access to resources Recommend Favorite

Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation

By Jones Cortney V   Copelan Edward A  

Future Oncology, Vol. 5, Iss. 4, 2009-05 ,pp. : 559-568

Future Medicine

Access to resources Recommend Favorite

Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 354-366

Bentham Science Publishers

Access to resources Recommend Favorite